SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,499.17 -455.59
( -0.58%)

Global Indices

Nasdaq

53,904.84 -465.28
(-0.86%)

Dow Jones

7,729.00 -15.55
(-0.20%)

Hang Seng

65,597.55 -85.71
(-0.13%)

Nikkei 225

10,909.12 41.23
(0.38%)

Forex

USD-INR

95.07 -0.16
(-0.17%)

EUR-INR

109.74 0.07
(0.06%)

GBP-INR

127.99 0.00
(0.00%)

JPY-INR

0.60 0.00
(-0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

66.2307167

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

64.08

4048.4

EPS(TTM)

Face Value()

Div & Yield %

6.3

0.02

Back

Regis Industries standalone net profit rises 29.41% in the June 2026 quarter

Aug 04,2026

Net profit of Regis Industries rose 29.41% to Rs 1.98 crore in the quarter ended June 2026 as against Rs 1.53 crore during the previous quarter ended June 2025. Sales rose 106.74% to Rs 5.83 crore in the quarter ended June 2026 as against Rs 2.82 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	5.83	2.82	107
OPM %	33.96	47.87	-
PBDT	1.98	1.53	29
PBT	1.98	1.53	29
NP	1.98	1.53	29

78,499.17 -455.59 ( -0.58%)

53,904.84 -465.28 (-0.86%)

7,729.00 -15.55 (-0.20%)

65,597.55 -85.71 (-0.13%)

10,909.12 41.23 (0.38%)

95.07 -0.16 (-0.17%)

109.74 0.07 (0.06%)

127.99 0.00 (0.00%)

0.60 0.00 (-0.16%)